Shopping Cart
- Remove All
- Your shopping cart is currently empty
NUC-7738 is a 5'-aryloxyphosphoamidate prodrug of 3'-dA that reduces β-catenin nuclear expression in AML cells, modulates β-catenin signaling, and can be used in cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $128 | In Stock |
Description | NUC-7738 is a 5'-aryloxyphosphoamidate prodrug of 3'-dA that reduces β-catenin nuclear expression in AML cells, modulates β-catenin signaling, and can be used in cancer research. |
Targets&IC50 | leukocyte lineage:<30 μM (LC50) |
In vitro | NUC-7738 has anticancer activity and cytotoxic activity against leukocyte lineage with LC50 <30 μM. 1 μM NUC-7738 has good stability in human hepatocytes with a t1/2 value of 48.1 min. NUC-7738 is more stable in human plasma compared with the parent nucleoside, and the plasma concentration remained unchanged for 4 hours. [1] |
Alias | NUC7738 |
Molecular Weight | 568.52 |
Formula | C26H29N6O7P |
Cas No. | 2348493-39-8 |
Smiles | O[C@H]1[C@H](N2C=3C(N=C2)=C(N)N=CN3)O[C@H](COP(OC4=CC=CC=C4)(N[C@H](C(OCC5=CC=CC=C5)=O)C)=O)C1 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (140.72 mM.), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.